{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:00:56Z","timestamp":1787313656956,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1038\/aps.2009.153","type":"journal-article","created":{"date-parts":[[2009,11,5]],"date-time":"2009-11-05T09:48:10Z","timestamp":1257414490000},"page":"1522-1528","source":"Crossref","is-referenced-by-count":33,"title":["Fenoterol, a \u03b22-adrenoceptor agonist, inhibits LPS-induced membrane-bound CD14, TLR4\/CD14 complex, and inflammatory cytokines production through \u03b2-arrestin-2 in THP-1 cell line"],"prefix":"10.1038","volume":"30","author":[{"given":"Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,11,5]]},"reference":[{"key":"BFaps2009153_CR1","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1056\/NEJMoa063070","volume":"356","author":"PM Calverley","year":"2007","unstructured":"Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356: 775\u201389.","journal-title":"N Engl J Med"},{"key":"BFaps2009153_CR2","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1136\/thx.2006.071068","volume":"62","author":"J Bourbeau","year":"2007","unstructured":"Bourbeau J, Christodoulopoulos P, Maltais F . Effect of salmeterol\/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial. Thorax 2007; 62: 938\u201343.","journal-title":"Thorax"},{"key":"BFaps2009153_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1183\/09031936.00145006","volume":"33","author":"MR Sears","year":"2009","unstructured":"Sears MR, Ottosson A, Radner F, Suissa S . Long-acting beta-agonists: a review of formoterol safety data from asthma clinical trials. Eur Respir J 2009; 33: 3\u20135.","journal-title":"Eur Respir J"},{"key":"BFaps2009153_CR4","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1165\/rcmb.2008-0037OC","volume":"40","author":"F Delavoie","year":"2009","unstructured":"Delavoie F, Molinari M, Milliot M, Zahm JM, Coraux C, Michel J, et al. Salmeterol restores secretory functions in cystic fibrosis airway submucosal gland serous cells. Am J Respir Cell Mol Biol 2009; 40: 388\u201397.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"BFaps2009153_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1136\/thx.2007.086256","volume":"63","author":"MA Matthay","year":"2008","unstructured":"Matthay MA, Lee J . Beta2 adrenergic agonist therapy may enhance alveolar epithelial repair in patients with acute lung injury. Thorax 2008; 63: 189\u201390.","journal-title":"Thorax"},{"key":"BFaps2009153_CR6","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1152\/ajplung.2000.279.4.L675","volume":"279","author":"P Farmer","year":"2000","unstructured":"Farmer P, Pugin J . \u03b2-Adrenergic agonists exert their \u201canti-inflammatory\u201d effects in monocytic cells through the I\u03baB\/NF-\u03baB pathway. Am J Physiol Lung Cell Mol Physiol 2000; 279: 675\u201382.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"BFaps2009153_CR7","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1177\/147323000403200503","volume":"32","author":"K Kuroki","year":"2004","unstructured":"Kuroki K, Takahashi HK, Iwagaki H, Murakami T, Kuinose M, Hamanaka S, et al. \u03b22-adrenergic receptor stimulation-induced immunosuppressive effects possibly through down-regulation of co-stimulatory molecules, ICAM-1, CD40 and CD14 on monocytes. J Int Med Res 2004; 32: 465\u201383.","journal-title":"J Int Med Res"},{"key":"BFaps2009153_CR8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/ni1569","volume":"9","author":"JC Kagan","year":"2008","unstructured":"Kagan JC, Su T, Horng T, Chow A, Akira S, Medzhitov R . TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat Immunol 2008; 9: 343\u20135.","journal-title":"Nat Immunol"},{"key":"BFaps2009153_CR9","doi-asserted-by":"publisher","first-page":"31051","DOI":"10.1074\/jbc.272.49.31051","volume":"272","author":"FT Lin","year":"1997","unstructured":"Lin FT, Krueger KM, Kendall HE, Daaka Y, Fredericks ZL, Pitcher JA, et al. Clathrin-mediated endocytosis of the beta-adrenergic receptor is regulated by phosphorylation\/dephosphorylation of beta-arrestin1. J Biol Chem 1997; 272: 31051\u20137.","journal-title":"J Biol Chem"},{"key":"BFaps2009153_CR10","doi-asserted-by":"publisher","first-page":"3712","DOI":"10.1073\/pnas.96.7.3712","volume":"96","author":"SA Laporte","year":"1999","unstructured":"Laporte SA, Oakley RH, Zhang J, Holt JA, Ferguson SS, Caron MG, et al. The beta2-adrenergic receptor\/betaarrestin complex recruits the clathrin adaptor AP-2 during endocytosis. Proc Natl Acad Sci USA 1999; 96: 3712\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFaps2009153_CR11","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/sj.emboj.7600991","volume":"25","author":"H Husebye","year":"2006","unstructured":"Husebye H, Halaas \u00d8, Stenmark H, Tunheim G, Sandanger \u00d8, Bogen B, et al. Endocytic pathways regulate Toll-like receptor 4 signaling and link innate and adaptive immunity. EMBO J 2006; 25: 683\u201392.","journal-title":"EMBO J"},{"key":"BFaps2009153_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jim.2005.07.026","volume":"313","author":"KA Remer","year":"2006","unstructured":"Remer KA, Brcic M, Sauter KS, Jungi TW . Human monocytoid cells as a model to study Toll\u2013like receptor-mediated activation. J Immunol Methods 2006; 313: 1\u201310.","journal-title":"J Immunol Methods"},{"key":"BFaps2009153_CR13","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/90609","volume":"2","author":"S Akira","year":"2001","unstructured":"Akira S, Takeda K, Kaisho T . Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001; 2: 675\u201380.","journal-title":"Nat Immunol"},{"key":"BFaps2009153_CR14","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1365-2567.2007.02781.x","volume":"124","author":"T Kizaki","year":"2008","unstructured":"Kizaki T, Izawa T, Sakurai T, Haga S, Taniguchi N, Tajiri H, et al. Beta2-adrenergic receptor regulates Toll-like receptor-4-induced nuclear factor-kappaB activation through beta-arrestin 2. Immunology 2008; 124: 348\u201356.","journal-title":"Immunology"},{"key":"BFaps2009153_CR15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/sj.cgt.7700544","volume":"10","author":"DP Cioca","year":"2003","unstructured":"Cioca DP, Aoki Y, Kiyosawa K . RNA interference is a functional pathway with therapeutic potential in human myeloid leukemia cell lines. Cancer Gene Therapy 2003; 10: 125\u201333.","journal-title":"Cancer Gene Therapy"},{"key":"BFaps2009153_CR16","doi-asserted-by":"publisher","first-page":"510","DOI":"10.2144\/00283st10","volume":"28","author":"JR Eldstrom","year":"2000","unstructured":"Eldstrom JR, La K, Mathers DA . Polycationic lipids translocate lipopolysaccharide into HeLa cells. Biotechniques 2000; 28: 510\u20136.","journal-title":"Biotechniques"},{"key":"BFaps2009153_CR17","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1189\/jlb.1105672","volume":"80","author":"SM Miggin","year":"2006","unstructured":"Miggin SM, O'Neill LA . New insights into the regulation of TLR signaling. J Leukoc Biol 2006; 80: 220\u20136.","journal-title":"J Leukoc Biol"},{"key":"BFaps2009153_CR18","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.4049\/jimmunol.173.5.3337","volume":"173","author":"M Ueta","year":"2004","unstructured":"Ueta M, Nochi T, Jang MH, Park EJ, Igarashi O, Hino A, et al. Intracellularly expressed TLR2s and TLR4s contribution to an immunosilent environment at the ocular mucosal epithelium. J Immunol 2004; 173: 3337\u201347.","journal-title":"J Immunol"},{"key":"BFaps2009153_CR19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neuint.2006.01.009","volume":"49","author":"J Szelenyi","year":"2006","unstructured":"Szelenyi J, Selmeczy Z, Brozik A, Medgyesi D, Magocsi M . Dual \u03b2-adrenergic modulation in the immune system: Stimulus-dependent effect of isoproterenol on MAPK activation and inflammatory mediator production in macrophages. Neurochem Int 2006; 49: 94\u2013103.","journal-title":"Neurochem Int"},{"key":"BFaps2009153_CR20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1242\/jcs.03338","volume":"120","author":"L Ma","year":"2007","unstructured":"Ma L, Pei G . Beta-arrestin signaling and regulation of transcription. J Cell Sci 2007; 120: 213\u20138.","journal-title":"J Cell Sci"},{"key":"BFaps2009153_CR21","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.molcel.2006.11.007","volume":"24","author":"RJ Lefkowitz","year":"2006","unstructured":"Lefkowitz RJ, Rajagopal K, Whalen EJ . New roles for beta-arrestins in cell signaling: not just for seven-transmembrane receptors. Mol Cell 2006; 24: 643\u201352.","journal-title":"Mol Cell"},{"key":"BFaps2009153_CR22","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1074\/jbc.M506576200","volume":"281","author":"SK Shenoy","year":"2006","unstructured":"Shenoy SK, Drake MT, Nelson CD, Houtz DA, Xiao K, Madabushi S, et al. Beta-arrestin-dependent, G protein-independent ERK1\/2 activation by the beta2 adrenergic receptor. J Biol Chem 2006; 281: 1261\u201373.","journal-title":"J Biol Chem"},{"key":"BFaps2009153_CR23","doi-asserted-by":"crossref","unstructured":"Bruchas MR, Macey TA, Lowe JD, Chavkin C . Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes. 2006; 281: 18081\u20139.","DOI":"10.1074\/jbc.M513640200"},{"key":"BFaps2009153_CR24","doi-asserted-by":"publisher","first-page":"49212","DOI":"10.1074\/jbc.M207294200","volume":"277","author":"Y Sun","year":"2002","unstructured":"Sun Y, Cheng Z, Ma L, Pei G . \u03b2-arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation. J Biol Chem 2002; 277: 49212\u20139.","journal-title":"J Biol Chem"},{"key":"BFaps2009153_CR25","doi-asserted-by":"publisher","first-page":"7478","DOI":"10.1073\/pnas.112198299","volume":"99","author":"AM Fong","year":"2002","unstructured":"Fong AM, Premont RT, Richardson RM, Yu YR, Lefkowitz RJ, Patel DD . Defective lymphocyte chemotaxis in beta-arrestin2- and GRK6-deficient mice. Proc Natl Acad Sci USA 2002; 99: 7478\u201383.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/aps2009153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps2009153","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps2009153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T08:21:22Z","timestamp":1684398082000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/aps2009153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["BFaps2009153"],"URL":"https:\/\/doi.org\/10.1038\/aps.2009.153","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}